Which has grown faster, MDXG or PRME?

Over the past five years, MDXG grew revenue faster — MDXG at a 6.36% CAGR versus PRME at -2.32%.

Is MDXG or PRME more profitable?

MDXG runs the higher net margin — MDXG at 1.76% versus PRME at -4613.11%.

MiMedx Group, Inc. (MDXG) vs Prime Medicine, Inc. (PRME)

A side-by-side comparison of MiMedx Group, Inc. and Prime Medicine, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

MDXG

MiMedx Group, Inc.

$673M

$4.62HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

PRME

Prime Medicine, Inc.

$632M

$3.50HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — MDXG vs PRME

growth of $100 · dividends reinvested · last 4y

MDXG +57.4% (+12.0%/yr)PRME -79.1% (-32.4%/yr)MDXG compounded faster over this window

Log scale — wide-divergence pair

MDXG PRME

MDXG vs PRME: by the numbers

•MDXG is the larger company ($673M vs $632M market cap).
•MDXG is profitable (1.76% net margin) while PRME runs a net loss (-4613.11%).
•MDXG grew revenue faster over the past five years (6.36% vs -2.32% CAGR).

Metrics side by side

Valuation

Metric	MDXG	PRME
P/E ratio	115.50	N/A
P/S ratio	1.90	155.21
P/B ratio	3.12	15.88
EV / EBITDA	26.41	N/A
FCF yield	6.03%	N/A

Profitability

Metric	MDXG	PRME
Gross margin	78.85%	-58.05%
Operating margin	15.26%	-4498.06%
Net margin	1.76%	-4613.11%
ROE	2.89%	-471.98%
ROIC	1.97%	-90.42%

Growth (annualized)

Metric	MDXG	PRME
Revenue CAGR (5Y)	6.36%	-2.32%
Total return CAGR (5Y)	-4.94%	N/A

Frequently asked

Which has grown faster, MDXG or PRME?: Over the past five years, MDXG grew revenue faster — MDXG at a 6.36% CAGR versus PRME at -2.32%.
Is MDXG or PRME more profitable?: MDXG runs the higher net margin — MDXG at 1.76% versus PRME at -4613.11%.

Go deeper

Full MDXG analysis Full PRME analysis Interactive comparison tool

Dig into the metrics

MiMedx P/E ratio MiMedx ROE Prime Medicine ROE MiMedx operating margin Prime Medicine operating margin MiMedx revenue growth Prime Medicine revenue growth MiMedx free cash flow Prime Medicine free cash flow

MiMedx & Prime Medicine appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.